Table 1 Demographics and clinical characteristics
Variables | hrHPV self-test (participants) | No hrHPV self-test (non-participants) | p-value |
|---|---|---|---|
n = 40 | n = 60 | ||
Age (years) at inclusion (median) (IQR) | 51.5 (42.3–56.0) | 49.0 (44.3–55.0) | 0.5 |
Age range at inclusion, n (%) | 0.4 | ||
23–40 years | 7 (17.5) | 7 (11.7) | |
41–64 years | 33 (82.5) | 53 (88.3) | |
Time (years) since HIV diagnosis, (median) (IQR) | 15 (12.0–24.0) | 16 (11.0–21.0) | 0.8 |
Time range since HIV diagnosis, n (%) | 0.6 | ||
0–10 years | 7 (17.5) | 14 (23.3) | |
11–20 years | 20 (50.0) | 31 (51.7) | |
> 20 years | 13 (32.5) | 15 (25.0) | |
Caucasians (ethnicity), n (%) | 15 (37.5) | 18 (30.0) | 0.8 |
Time (years) since last CC screening, (median) (IQR) | 3 (2.0–6.0) | 4 (2.0–8.0) | 0.4 |
Time range since last CC screening, n (%) | 0.9 | ||
3–5 years | 24 (60.0) | 35 (58.3) | |
> 5 years | 9 (22.5) | 16 (26.7) | |
Never screened | 7 (17.5) | 9 (15.0) | |
Quantitative HIV RNA range, n (%) | 0.6 | ||
Undetectable | 35 (87.5) | 54 (90) | |
< 50 copies/ml | 3 (7.5) | 5 (8.3) | |
> 50 copies/ml | 2 (5.0) | 1 (2.7) |